A detailed history of Tiedemann Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 5,032 shares of EW stock, worth $340,968. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,032
Previous 5,032 -0.0%
Holding current value
$340,968
Previous $474,000 26.58%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

BUY
$81.41 - $94.33 $19,375 - $22,450
238 Added 4.96%
5,032 $474,000
Q2 2022

Aug 03, 2022

SELL
$86.5 - $128.27 $23,960 - $35,530
-277 Reduced 5.46%
4,794 $456,000
Q1 2022

Apr 27, 2022

BUY
$101.96 - $128.34 $17,537 - $22,074
172 Added 3.51%
5,071 $596,000
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $531 - $653
-5 Reduced 0.1%
4,899 $635,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $232,782 - $277,660
-2,262 Reduced 31.57%
4,904 $556,000
Q2 2021

Aug 12, 2021

BUY
$83.84 - $104.76 $157,283 - $196,529
1,876 Added 35.46%
7,166 $742,000
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $16,522 - $19,040
210 Added 4.13%
5,290 $442,000
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $3,082 - $3,922
43 Added 0.85%
5,080 $463,000
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $31,041 - $40,397
-462 Reduced 8.4%
5,037 $402,000
Q2 2020

Nov 12, 2020

BUY
$57.54 - $76.95 $81,649 - $109,192
1,419 Added 34.78%
5,499 $380,000
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $129,062 - $172,598
2,243 Added 122.1%
4,080 $282,000
Q1 2020

May 07, 2020

BUY
$52.41 - $81.0 $16,194 - $25,029
309 Added 20.22%
1,837 $346,000
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $35,419 - $40,552
-494 Reduced 24.43%
1,528 $357,000
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $40,376 - $49,482
656 Added 48.02%
2,022 $444,000
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $459,297 - $530,738
-8,240 Reduced 85.78%
1,366 $252,000
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $231,979 - $310,258
4,844 Added 101.72%
9,606 $1.84 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $157,886 - $193,709
3,402 Added 250.15%
4,762 $729,000
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $8,911 - $11,315
-195 Reduced 12.54%
1,360 $237,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $89,696 - $108,396
-2,113 Reduced 57.61%
1,555 $226,000
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $1.44 Million - $1.83 Million
-38,629 Reduced 91.33%
3,668 $512,000
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $235,812 - $252,317
6,498 Added 18.15%
42,297 $1.08 Million
Q2 2017

Aug 14, 2017

BUY
N/A
35,799
35,799 $4.23 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Tiedemann Advisors, LLC Portfolio

Follow Tiedemann Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.